ATAI Life Sciences NV held an extraordinary general meeting of shareholders on November 4, 2025. Shareholders approved the acquisition of Beckley Psytech Limited, the issuance of shares, amendments to the company's articles of association to effect a name change, and the merger of ATAI with ATAI Life Sciences Luxembourg S.A., with ATAI Life Sciences Luxembourg S.A. surviving the merger. An amendment to the articles of association related to cash compensation for shareholders exercising withdrawal rights in connection with the merger was also approved.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ATAI Life Sciences NV published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001140361-25-040358), on November 04, 2025, and is solely responsible for the information contained therein.
Comments